266 related articles for article (PubMed ID: 20845688)
1. [A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].
Wakabayashi K; Yano S; Kobayashi K; Kadowaki T; Kimura M; Ishikawa S; Ikeda T
Kekkaku; 2010 Aug; 85(8):679-82. PubMed ID: 20845688
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
3. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
Hongthiamthong P; Chuchottaworn C; Amatayakul N
J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
[TBL] [Abstract][Full Text] [Related]
5. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
7. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
Reichlin S; Frei R; Reusser P
Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
[TBL] [Abstract][Full Text] [Related]
9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
10. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
11. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
12. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
15. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
[TBL] [Abstract][Full Text] [Related]
16. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
17. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
18. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
19. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
